Aura Biosciences, Inc.
AURA
$7.93
-$0.26-3.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.19% | 3.29% | 1.69% | -6.38% | -22.77% |
| Total Depreciation and Amortization | -2.86% | -2.10% | -1.72% | 0.00% | -7.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.90% | -4.81% | 15.17% | 34.78% | 21.90% |
| Change in Net Operating Assets | -20.63% | -3.16% | 379.20% | 144.90% | -127.89% |
| Cash from Operations | -1.61% | 3.03% | 11.05% | 2.49% | -56.83% |
| Capital Expenditure | -291.11% | -15.38% | 79.14% | 37.46% | 12.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 168.22% | -319.69% | -33.28% | 0.02% | 193.20% |
| Cash from Investing | 167.75% | -320.35% | -32.99% | 0.40% | 200.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -36.58% | -90.62% | 48,357.29% | -82.32% | -24.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | -36.58% | -93.76% | 72,742.71% | -82.32% | -24.16% |
| Foreign Exchange rate Adjustments | -1,042.86% | -255.56% | 142.86% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.00% | -186.51% | 958.33% | 3.93% | 234.66% |